Application no. and date | 10728558.7 (espacenet) (Federated) (European Patent Register), 20100628 | Patent/reg. no. and date | DK/EP 2448933, 20130828 | Publication date | 20120509 | Priority no. and date | US 221708 P, 20090630 | EP pub. no. and date |
EP 2448933 20120509 | Effective date | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | P81311273DK00E | Inventor | CHEN, Xinchao, Eli Liily And Company Lilly Corporate Center
Indianapolis, Indiana 46285, US, FRANK, Scott, Alan, Eli Lilly And Company Lilly Corporate Center
Indianapolis, Indiana 46285, US, REMICK, David, Michael, Eli Lilly And Company Lilly Corporate Center
Indianapolis, Indiana 46285, US, PEDERSEN, Steven, Wayne, Eli Lilly And Company Lilly Corporate Center
Indianapolis, Indiana 46285, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/55 (2006.01) , A61P 9/10 (2006.01) , C07D 403/12 (2006.01) | Title | Trans-4-[[(5S)-5-[[[3,5-bis(trifluormethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexancarboxylsyre | Int. application no. | US2010040125 | Int. publication no. | WO2011002696 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|